1 2 3 4 5 6
slide-left slide-left

News & Events

  •   Drugs & Treatment  
  •   Industry News  
  •   Healthcare Legislation, Regulation & Medicaid/Medicare  
  •   Others  

Hospitals Scramble on the Front Lines of Drug Shortages
Washington Post (04/10/12) Sun, Lena H.

Shortages of prescription drugs nearly tripled from 2005 to 2010 and reached record levels in 2011. Many manufacturers met with production problems and stopped operations, sending the U.S. Food and Drug Administration (FDA) into read more...

J&J Working to Boost Supply of Cancer Drug Doxil by September
Bloomberg (04/09/12) Cortez, Michelle Fay

Johnson & Johnson hopes to resume production of the cancer medicine Doxil by September. In November 2011, a production shutdown at BoehringerIngelheim GmbH's Ben Venue Laboratories factory in Ohio contributed to   read more...

Mortality Risk in Heart Failure No Higher with Losartan
MedPage Today (04/10/12) Neale, Todd

A Danish study reported in April 11 issue of the Journal of the American Medical Association showed that patients with heart failure who were taking losartan did not have a higher mortality risk than those on candesartan. The study showed   read more...

Qualitest Pharmaceuticals Receives FDA Approval for Levetiracetam Oral Solution, 100 mg/mL
Endo Pharmaceuticals Press Release (04/12/12)

Qualitest Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved Levetiracetam Oral Solution, 100mg/mL.Qualitest plans to begin distribution in mid-2012. Qualitest is an   read more...

AstraZeneca Launches DUTOPROL Tablets for High Blood Pressure in U.S.
AstraZeneca Press Release (04/12/12)

AstraZeneca has announced the availability of a once-daily anti-hypertensive agent that provides proven blood pressure reduction at 24 hours. Rather than using a traditional payer contraction strategy, AstraZeneca has launched   read more...

Express Scripts Aims to Predict Medicine Problems
Associated Press (04/15/12) Murphy, Tom

Pharmacy benefits manager Express Scripts hopes that a new product will help patients stay on their meds by predicting who who will stop taking prescriptions before a patient actually does it. The computer program ScreenRx sifts through read more...

Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate Vintafolide
Merck Press Release (04/16/12)

Merck and Endocyte have announced that they have entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide (EC145). Vintafolide is currently being evaluated in a   read more...

U.S. Adds More on Clot Risk to Some Birth Control Pills (04/11/12)

A study by the FDA has shown that birth control pills containing drospirenone have a higher risk of causing blood clots than other contraceptive drugs. Regulators are going to be including this information on the labels of   read more...

DabigatranEtexilate Associated With Significantly Lower Rates of Fatal and Traumatic Intracranial Haemorrhage Compared With Warfarin BoehringerIngelheim Pharmaceuticals Press Release (04/18/12)
A new analysis of the 18,113 patient, RE-LY trial highlights significantly lower rates of both fatal and traumatic intracranial haemorrhage in patients treated with dabigatranetexilate (Pradaxa) 110mg and 150mg bid compared to   read more...

First Ever Data Investigating Interferon-free Treatment in Hepatitis C Patients Who Have Liver Cirrhosis Shows High Viral Cure Rate
BoehringerIngelheim Pharmaceuticals Press Release (04/19/12)

New data from the SOUND-C2 study shows that up to 71 percent of patients with hepatitis C and liver cirrhosis achieved a viral cure, after just 28 weeks of treatment. These patients, who had a prevalent type of   read more...

Painkiller Overdose Epidemic Spreading to Teens, CDC Says
Medscape (04/16/12) Lowes, Robert

The latest Morbidity and Mortality Weekly Report published by the Centers for Disease Control and Prevention shows that fatal overdoses with prescription analgesics are the main cause of the 91 percent increase in accidental   read more...

Merck Reports Phase III Study Results Evaluating Anemia Management Strategies Used With VICTRELIS Combination Therapy
Merck Press Release (04/19/12)

Merck has announced the final results of a Phase III, open-label study which was designed to compare the impact of two anemia management strategies on sustained virologic response (SVR) in patients with chronic   read more...

Migraine Headaches: New Guidelines Focus on Prevention
ABC News (04/23/12) Moisse, Katie

From prescription pills to poisonous plants, plenty of treatments can help prevent migraines, according to new guidelines from the American Academy of Neurology. Researchers reviewed a slew of studies on migraine prevention to tease out    read more...

Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease
Sanofi-Aventis Press Release (04/19/12

Sanofi announced that it will be collaborating with the Michael J. Fox Foundation (MJFF) to conduct a clinical trial of AVE 8112, a Sanofiphosphodiesterase type 4 (PDE4) inhibitor in patients with Parkinson's disease (PD). The chief executive officer of    read more...

Two Phase 3 Studies on Ultra-Long-Acting Insulin Degludec Published
Novo Nordisk Press Release (04/20/12)

Ultra-long-acting insulin degludec, an investigational compound from Novo Nordisk, has been featured in two studies in The Lancet showing a significant reduction in the rates of nocturnal hypoglycemia by 25 percent, compared to    read more...

FDA Approves First Generic Lexapro to Treat Depression, Anxiety Disorder
Drug Topics (03/14/12)

The first generic version of Lexapro has now been approved by the FDA and will be sold exclusively by Teva/IVAX Pharmaceuticals for 180 days.The drug, which is approved to treat    read more...

FDA Approves First Oral Contraceptive to Treat Heavy Menstrual Bleeding
Drug Topics (03/15/12)

The FDA has approved the use of Natazia, an oral contraceptive, for the treatment of heavy menstrual bleeding (HMB) that is not caused by a diagnosed condition of the uterus. It is the   read more...

Fabry Drug Move a Blow for Shire, Boon for Sanofi
Reuters (03/15/12)

An unexpected decision by Shire to pull its U.S. application to sell Fabry disease drug Replagal is a blow for the firm's aspirations in treating rare diseases but a boon for rival   read more...

Gender Gap in Medication Management
News-Medical (03/19/12)

There is a wide gender divide when it comes to how men and women are prescribed and adhere to their medications. According to a new study, while women use more prescription drugs than men, they are less   read more...

New Type 2 Diabetes Drug Helps Lower Blood Sugar: Study
U.S. News & World Report (03/19/12) Gordon, Serena

A new type of medication for type 2 diabetes helps to lower blood sugar levels when used in concert with insulin and other diabetes drugs, new research suggests. The medicine is called   read more...

Percentage of Child Deaths by Meds Poisoning Rising
CNN Health (03/20/2012)

Each day roughly about 165 young kids in the United States are seen in emergency rooms after getting into medications, according to findings revealed in a report by Safe Kids Worldwide, which unveiled a read more...

Statin Drug Linked to Lower Pneumonia Risk
Reuters (03/19/12) Norton, Amy

People who use statins may have a slightly lower risk of developing pneumonia than non-users do, a study out Monday concludes. Researchers found that of nearly 18,000 adults in a   read more...

AstraZeneca Announces Increased Coverage of BRILINTA Through Plan Preferred Formulary Status on Medco Health Solutions
AstraZeneca Press Release (03/22/12)

AstraZeneca has announced that BRILINTA (ticagrelor) tablets received Plan Preferred Tier 2 formulary access on Medco Health Solutions’ National commercial formulary and Preferred Brand formulary status on   read more...

FDA Approves First Generic Versions Of Osteoporosis Drug Boniva RTTNews (03/20/12)
The Food and Drug Administration has approved the first generic versions of Genentech's Boniva, a once-a-moth product used to treat or prevent osteoporosis in women. Generic manufacturers   read more...

Investigational Study May Help Researchers Develop Test That Predicts Risk of Imminent Heart Attacks
Johnson & Johnson Press Release (03/21/12)

Veridex, a Johnson & Johnson company, has announced the publication of a new, investigational study published this week in Science Translational Medicine that lays the foundation for research that may   read more...

Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus
Merck Press Release (03/20/12)

Merck and ARIAD Pharmaceuticals have announced that the FDA's Oncologic Drugs Advisory Committee voted 13 to 1 against the use of the investigational agent ridaforolimus as maintenance therapy for   read more...

New Drug Bests Standard Treatment for Certain Strokes
U.S. News & World Report (03/21/12) Gordon, Serena

The results of a study on two different thrombolytic treatments for acute ischemic strokes by Australian researcher was published in the March 22 issue of the New England Journal of Medicine. The study compared   read more...

BoehringerIngelheim and Lilly's Jentadueto Tablets Now Available in U.S. Pharmacies
Eli Lilly and Company Press Release (03/07/12)

BoehringerIngelheim Pharmaceuticals and Eli Lilly have announced that Jentadueto (linagliptin/metformin hydrochloride) tablets are now available by prescription in many leading chain and   read more...

Ethicon Endo-Surgery Brings Hands-On Lab Training Experience to Society of American Gastrointestinal and Endoscopic Surgeons Conference
Johnson & Johnson Press Release (03/06/12)

Ethicon Endo-Surgery (EES) demonstrated its latest product innovations and best practices in minimally-invasive procedures focused on improving clinical outcomes and the quality of patient care at   read more...

AARP Study Says Price of Popular Drugs Rose 26%
New York Times (03/06/12) Thomas, Katie

A report issued by AARP found that the retail prices of the 514 drugs most widely used by Medicare recipients had risen around 26 percent between 2005 and 2009. Though the price of the generics on   read more...

Discovery Labs Wins Approval for Drug to Ease Baby Breathing
Bloomberg (03/06/12) Edney, Anna

The FDA has granted approval to Discovery Laboratories' drug Surfaxin on the fifth try for market approval since 2004. Surfaxin was developed to prevent respiratory distress in premature infants, as it   read more...

Estrogen Replacement Therapy Safe for Some Menopausal Women
USA Today (03/06/12) Szabo, Liz

A study from the Women's Health Initiative, published online in The Lancet Oncology, suggests that for the 30 percent of menopausal women who have had hysterectomies, taking estrogen supplements for   read more...

FDA Responds to AstraZeneca Citizen Petitions on Quetiapine Product Labeling
AstraZeneca Press Release (03/08/12)

The FDA has denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that   read more...

Painkiller Developers Win FDA Advisory Panel’s Backing to Continue Studies
Bloomberg BusinessWeek (03/12/12) Edney, Anna

Pfizer, Johnson & Johnson, and Regeneron Pharmaceuticals won the backing of a U.S. advisory panel to continue development of a class of experimental painkillers that have been linked to   read more...

Prescription Painkillers for Outpatient Surgeries May Lead to Long-Term Use
ABC News (03/12/12) Conley, Mikaela

Older adults who receive pain medications after surgery may be at higher risk of becoming addicted, according to a new study published in the journal Archives of Internal Medicine. Researchers analyzed   read more...

Researchers Identify Promising New Drug Target for Kidney Disease
Medical Xpress (03/11/12)

Mount Sinai School of Medicine researchers have found a regulator protein that plays a crucial role in kidney fibrosis, and are planning on using this knowledge to develop a new drug intervention that   read more...

Study Unblinded: ZYTIGA Plus Prednisone for Chemotherapy-Naïve Patients With Metastatic Metastatic Castration-Resistant Prostate Cancer
Johnson & Johnson Press Release (03/08/12)

Janssen Research & Development has announced that it has unblinded the Phase 3 study of ZYTIGA (abiraterone acetate) plus prednisone for the treatment of asymptomatic or mildly symptomatic patients with   read more...

U.S. Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg (03/08/12) Edney, Anna

The Food and Drug Administration has asked an advisory panel whether Pfizer and Johnson & Johnson should resume human trials on a class of experimental painkillers linked to joint failure. Studies on the   read more...

Vitamin D Linked to Stronger Bones in Girls
Los Angeles Times (CA) (03/05/12) Roan, Shari

A study published online in the Archives of Pediatric and Adolescent Medicine by researchers from Children's Hospital Boston analyzed the intake of calcium, vitamin D, and dairy products by 6,721 girls ranging in   read more...


Unique Services

Savings made simple
Discounts at your services
Customer service
Every member is unique
Read More..